Status:
NOT_YET_RECRUITING
Effects of a Group Versus Individual Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment
Lead Sponsor:
University of Salamanca
Conditions:
Breast Cancer Females
Oncology
Eligibility:
All Genders
Phase:
NA
Brief Summary
Introduction: The significant improvement in breast cancer survival, largely attributable to biomedical and technological progress, makes it increasingly necessary to investigate the secondary effects...
Eligibility Criteria
Inclusion
- Being an adult (18 years or older). Having a recent histopathological diagnosis of newly diagnosed breast cancer and starting oncological treatment.
- Being fully capable of performing daily functions. Willingness to voluntarily participate in the study and signing the informed consent.
Exclusion
- Lack of literacy skills or significant language comprehension deficit. Diagnosis of a Central Nervous System tumor or participation in another cognitive stimulation program.
- Clinical diagnosis of a neurocognitive disorder as defined in the DSM-V.
- Withdrawal Criteria:
- Dropping out of the program or not completing the final evaluation
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT07165912
Start Date
November 1 2025
End Date
December 31 2026
Last Update
September 10 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Juan Luis
Salamanca, Spain, 37004
2
Juan Luis
Salamanca, Spain, 37004